Related Experiment Video
Updated: Aug 22, 2025
06:39
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
15.9K
Effects of Theacrine as a Pre-Workout Supplement
Henrique Santa Capita Cerqueira1, Hugo Tourinho Filho2, Marcos Corrêa Junior1
1Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14876-018, Brazil.
International Journal of Environmental Research and Public Health
|November 11, 2022
Summary
Theacrine, a caffeine-like supplement, was studied for its effects on athletic performance. This research found no significant improvements in physical performance for young male athletes supplementing with theacrine.
Area of Science:
- Sports Science
- Nutritional Biochemistry
Background:
- Athletes seek performance enhancement through nutritional strategies.
- Theacrine, a caffeine-analogous alkaloid, is explored for its potential ergogenic effects.
- Limited research exists on theacrine's impact on physical performance.
Purpose of the Study:
- To investigate the effects of theacrine supplementation on physical performance in young male athletes.
- To evaluate theacrine's efficacy using a battery of standardized physical tests.
Main Methods:
- A randomized, controlled trial involving 22 male amateur flag-football athletes.
- Participants were divided into theacrine and placebo groups.
- Physical performance was assessed via jump, agility, sprint, and endurance tests before and after supplementation.
Main Results:
- No statistically significant differences were observed between the theacrine and placebo groups across all tested physical performance metrics.
- Theacrine supplementation did not enhance performance in jumping, agility, sprinting, or endurance.
Conclusions:
- The findings do not support the use of theacrine as a supplement for improving physical performance in young male athletes.
- Further research may be needed to explore potential alternative applications or dosages of theacrine.
Related Concept Videos
01:28Adrenergic Agonists: Mixed-Action Agents
818
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
818
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.2K
01:30Adrenergic Agonists: Therapeutic Uses
889
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
889
01:25Adrenergic Agonists: Indirect-Acting Agents
1.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.8K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
750
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
750
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.5K